Mirikizumab Shows Promise for Ulcerative Colitis Treatment
An estimated 50% of people living with ulcerative colitis, a form of inflammatory bowel disease, experience moderate-to-severe symptoms that available treatments fail to control. An urgent need to defecate, bloody…